In this issue:
Superficial needling acupuncture no better than sham for knee OA
Systemic rheumatic diseases in hospitalised patients with COVID-19
Methotrexate: response to the BNT162b2 COVID-19 vaccine
HLA-DRB1 risk alleles for RA and clinical response to abatacept and adalimumab
Initiating febuxostat does not prolong acute gout flare
Relapse risk in giant cell arteritis treated with tocilizumab
TPX-100 in knee OA: bone shape change and cartilage stabilisation
Adverse events with methotrexate for RA
Associations of biologic/targeted synthetic DMARDs with COVID-19 severity in RA
Effectiveness and safety of a T2T strategy for elderly-onset RA
Please login below to download this issue (PDF)